Q2 2019 Verastem Inc Earnings Call Transcript
Good afternoon, and welcome to the Verastem Oncology Second Quarter Financial Results Conference Call on Thursday, August 1, 2019. (Operator Instructions) Please be advised that this call is being recorded at the company's request and will be available in the company's website for a period of 90 days from today.
At this time, I would like to introduce Mr. John Doyle, Vice President of Investor Relations and Finance at Verastem Oncology. Please go ahead.
Welcome, everyone, and thank you for joining us this afternoon to discuss Verastem Oncology's financial results and corporate highlights for the second quarter of 2019. I'm joined today by Brian Stuglik, Chief Executive Officer; Dan Paterson, President and Chief Operating Officer; and Rob Gagnon, Chief Financial and Business Officer.
During today's call, Dan will provide some introductory comments, including introducing our new CEO, Brian Stuglik. Brian and Dan will discuss the key corporate updates from the quarter, and Rob will provide an
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |